SCHEMBL8346159

SCHEMBL8346159

Cc1c(/C(=C\C(=O)O)c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
HSD17B10 Q99714 4/20 0.51
HPGD P15428 4/20 0.48
MAPT P10636 4/20 0.48
HTT P42858 2/20 0.48
USP2 O75604 1/20 0.48
KDM4E B2RXH2 5/20 0.46
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
LMNA P02545 1/20 0.46
MAOA P21397 1/20 0.45
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
DAO P14920 1/20 0.44
DDO Q99489 1/20 0.44
GFER P55789 2/20 0.43
AHR P35869 1/20 0.43
POLB P06746 1/20 0.43
FOLH1 Q04609 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8346343 0.84 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL8346132 0.84 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL8346341 0.84 ALDH1A1 (0.47) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL8343752 0.81 ALDH1A1 (0.56) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL2399274 0.80 ALDH1A1 (0.63) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL29897041 0.80 ALDH1A1 (0.63) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL8350787 0.79 ALDH1A1 (0.49) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL2722021 0.77 ALDH1A1 (0.63) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL10704376 0.75 ALDH1A1 (0.61) ALDH1A1HSD17B10HPGDMAPTHTT
SCHEMBL4493831 0.74 MAP2 (0.60) ALDH1A1HSD17B10HPGDMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0802902-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1997-10-29 EP disclosed
WO-1996021644-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1996-07-18 WO disclosed